Effects of epeleuton, a novel synthetic second-generation n-3 fatty acid, on non-alcoholic fatty liver disease, triglycerides, glycemic control, and cardiometabolic and inflammatory markers

John Climax, Philip N. Newsome, Moayed Hamza, Markus Weissbach, David Coughlan, Naveed Sattar, Darren K. McGuire, Deepak L. Bhatt

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of epeleuton, a novel synthetic second-generation n-3 fatty acid, on non-alcoholic fatty liver disease, triglycerides, glycemic control, and cardiometabolic and inflammatory markers'. Together they form a unique fingerprint.

Medicine & Life Sciences